NANAFARM
Board
1 director, no change since 2024Director (not named in the articles)
appointed by deed of 25-03-2024
listed in the 2025 annual accounts, filed on 31-10-2025
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 25-03-2024
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
BoardEarlier
Mandates as a list
-
- Manager, appointed by deed of 09-06-2017, until 25-03-2024
- Director (not named in the articles), appointed by deed of 25-03-2024, still in office
Control
Founder
This company
NANAFARM
Equity €271,646
Loss €10,616 in 2025
Capital
- Contribution
- €45,000
- Shares
- 1,000
- Contribution per share
- €45
- Equity per share
- €272 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 25-03-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of September at 20:00
Founder
At incorporation
deed of 09-06-2017 ↗
- sole founder · 100% at incorporation
Capital transactions
Capital over time
- 25-03-2024 Converted to unavailable equity · €49,500
- 09-06-2017 Incorporation · €45,000 · 1,000 shares